Introduction
Growth factors and cytokines (e.g., insulin-like growth factor-1, interleukin-1, tumor necrosis factor) are known to modulate apoptosis induction pathways, resulting either in cytoprotection or enhanced cell killing (Resnico et al., 1995; Singleton et al., 1996; Friedlander et al., 1996; Rodriguez et al., 1996; Schulze-Ostho et al., 1998) . The modulation of apoptosis by these agents is receptor-mediated, although in most cases, the downstream events leading to enhanced or reduced survival have not been fully elucidated.
Hepatocyte growth factor/scatter factor (HGF/SF) is a cytokine/growth factor previously implicated as a mediator of cell motility and invasion, epithelial morphogenesis, angiogenesis, and cellular transformation (Stoker et al., 1987; Grant et al., 1993; Rong et al., 1992; Weidner et al., 1996) . HGF/SF accumulates in tumors, such as breast cancers, with the highest levels observed in the most invasive and biologically aggressive cancers (Yamashita et al., 1994; Yao et al., 1996; Jin et al. 1997) . Several prior studies have implicated HGF/SF as a mediator of protection against apoptosis and of cell survival. Thus, pretreatment with HGF/SF blocked apoptosis of MadinDarby canine kidney (MDCK) epithelial cells induced by loss of adherence to the substratum (Frisch and Francis, 1994) ; and disruption of expression of integrin a 2 b 1 blocked the morphogenetic response to HGF/SF and precipitated entry into apoptosis (Saelman et al., 1995) . Furthermore, expression of a constitutively active, oncogenic form of the c-Met tyrosine kinase, the canonical HGF/SF receptor (Bottaro et al., 1991) , blocked apoptosis and allowed immortalization of hepatocytes (Amicone et al., 1997) ; and association of an anti-apoptotic protein (BAG-1) with the c-Met receptor was found to contribute to HGF/SF-mediated inhibition of apoptosis induced by the protein kinase inhibitor staurosporine (Bardelli et al., 1996) .
Recently, we reported that HGF/SF potently protects various epithelial and carcinoma cell types from apoptosis induced by DNA-damaging agents, including: adriamycin (a DNA topoisomerase II inhibitor), ultraviolet light (which causes DNA photoproduct lesions), and ionizing X-rays (which cause breakage of the sugar-phosphate backbone of DNA) (Fan et al., 1998a) . HGF/SF-mediated protection of these cell lines was dependent upon the c-Met receptor; and the protection was blocked by a truncated form of the HGF/SF protein, NK1, which can function as an antagonist or partial agonist of c-Met receptor activation in dierent contexts. Cytoprotection by HGF/SF required pre-treatment for several days prior to exposure to the cytotoxic agent, suggesting that new protein synthesis may be required for protection.
Further investigation of potential apoptosis regulatory pathways revealed that in the human breast cancer cell line MDA-MB-453, HGF/SF treatment blocked the adriamycin induced down-regulation of expression of Bcl-X L (Fan et al., 1998a) , an anti-apoptotic protein related to Bcl-2 (Boise et al., 1993) . The proteins that regulate apoptosis (e.g., Bcl-2/Bax gene family, c-Myc transcriptional system, Fas/Fas ligand, caspase family) are not known to be directly involved in the DNA repair process (Chao and Korsemeyer, 1998; Packham et al., 1996; Schulze-Ostho et al., 1998; Depraetere and Goldstein, 1997) . However, recent studies suggest a linkage between the cellular apoptosis and DNA repair systems. For example, p53 ± a protein that recognizes chromosomal alterations and induces the transcription of genes that mediate apoptosis (e.g., Bax) ± can also participate directly in certain forms of DNA repair, such as nucleotide excision repair (Wang et al., 1995; Oer et al., 1999) . And the breast cancer susceptibility gene product BRCA1 both induces apoptosis (Shao et al., 1996; Fan et al., 1998b) and participates in the repair of radiation induced damage to DNA (Husain et al., 1998; Gowen et al., 1998) .
Here, we report that HGF/SF not only protects cells against apoptosis, but also stimulates DNA repair activity. Thus, HGF/SF-mediated protection of carcinoma cells against DNA-damaging agents may result not only from activation of an anti-apoptosis pathway, but also from a reduction in the number of residual DNA strand breaks as a function of time after agent exposure. These biologic eects of HGF/SF could be mimicked by the expression of a Bcl-X L transgene and blocked by an inhibitor of PI3K.
Results
Pre-treatment with HGF/SF enhances cellular DNA repair activity Cells were pre-treated with 100 ng/ml of HGF/SF for 2 days; then exposed to the DNA damaging agents adriamycin (ADR), a topoisomerase II a inhibitor or to 60 Co gamma rays; post-incubated in fresh drug-free culture medium for 24 h post agent exposure; and analysed for DNA strand breaks using the DNA ®lter elution assay (DFEA). Pre-incubation with HGF/SF had no eect on the number of single-strand breaks (SSBs) or double-strand breaks (DSBs) induced by ADR in MDA-MB-453 cells at T=0 h post ADR exposure (data not shown). However, by T=24 h post ADR exposure, there were fewer residual DNA breaks in HGF/SF-treated cells than in sham-treated control cells. These ®ndings suggest that pre-treatment with HGF/SF does not aect the initial generation of DNA breaks but causes an increase in the rate of repair of these breaks during the 24 h period after exposure to ADR.
HGF/SF also enhanced the repair of SSBs and DSBs in MDA-MB-453 cells exposed to 60 Co gamma rays (Figure 1a) . Similar results were obtained when T47D breast cancer (Figure 1b ) and DU-145 prostate cancer ( Figure 1c ) cells were pre-treated+HGF/SF and then exposed to ADR or gamma radiation. Thus, preincubation with HGF/SF caused an increase in the rate of repair of DNA strand breaks during the 24 h Figure 1 Pre-treatment of human cancer cell lines with HGF/SF enhances DNA repair activity. Subcon¯uent proliferating cells were pre-incubated+HGF/SF (100 ng/ml648 h) in complete culture medium; exposed to adriamycin (ADR) (2 h at 378C) or to 60 Co gamma rays (258C), washed, and post-incubated for T=24 h in fresh drug-free culture medium. The number of DNA single-strand breaks (SSBs) or double-strand breaks (DSBs) were determined by DNA ®lter elution assays and expressed as the fraction of DNA eluted minus that for sham-treated control cells. Results are shown for MDA-MB-453 (a) and T47D (b) breast cancer cells and for DU-145 prostate cancer cells (c). Values are means of duplicate assays, with ranges within+5% of the mean values. Note: Figure 1 shows representative experiments. HGF/SF is abbreviated as SF in this and subsequent ®gures interval after exposure to ADR, a DNA topoisomerase II a inhibitor, and gamma rays, which cause breaks of the sugar-phosphate backbone by free radical attack of DNA.
Effect of BRCA1 on SF-mediated cytoprotection
The tumor suppressor proteins p53 and BRCA1 have been implicated in DNA repair and apoptosis pathways. Each of the cell lines tested in Figure 1 has a p53 gene mutation: MDA-MB-453 has a deletion mutation resulting in loss of p53 protein; while T47D and DU-145 each express a dierent mutated p53 protein. Thus, it is unlikely that protection by SF is due to alteration of p53 signaling pathways. We had available DU-145 cell lines stably transfected with a wild-type BRCA1 (wtBRCA1) gene under control of the CMV promoter (Fan et al., 1998b) . To determine if expression of BRCA1 in¯uences the SF-mediated protection, we tested the ability of SF to protect DU-145 cells transfected with wtBRCA1 or empty pcDNA3 vector.
As shown in Figure 2 , expression of wtBRCA1 failed to abrogate the ability of HGF/SF to protect DU-145 cells against ADR, as compared with its ability to protect control (neo) transfected DU-145 cells. The viability of (HGF/SF+ADR) treated wtBRCA1 cell lines was less than that of (HGF/SF+ADR) treated control cells, indicating that HGF/SF does not fully reverse the BRCA1-mediated chemosensitization of DU-145 cells. These ®ndings suggest that HGF/SF acts down-stream of BRCA1 or functions to partially reverse BRCA1-induced alterations that lead to chemosensitivity.
Effect of Bcl-X L expression on cytotoxicity and DNA repair activity in MDA-MB-453 cells Previously, we reported that exposure of MDA-MB-453 cells to ADR caused a decrease in the levels of Bcl-X L , an anti-apoptotic protein related to Bcl-2, and that HGF/SF blocked the ADR-induced down-regulation of Bcl-X L (Fan et al., 1998a) . We hypothesized that protection of MDA-MB-453 cells by HGF/SF was due, in part, to an anti-apoptosis pathway involving Bcl-X L . Bcl-X L is not known to participate in DNA repair. Thus, in principle, enforced expression of Bcl-X L should mimic the component of HGF/SF protection due to the Bcl-X L survival pathway but should not aect the component of protection due strictly to the DNA repair process. To examine this hypothesis, we established MDA-MB-453 cell clones stably transfected with a Bcl-X L expression vector or with the empty Bcl-X L vector (neo).
The basal levels of Bcl-X L protein in MDA-MB-453 cell clones transfected with Bcl-X L were only slightly to moderately higher than those of control (neo) transfected clones. However, after treatment with ADR, the Bcl-X L levels of the Bcl-X L transfected cells remained high; while the Bcl-X L levels of the neo clones dropped markedly (Figure 3a) . Thus, the transfection of Bcl-X L mimics the ability of HGF/SF to block the ADR-induced down-regulation of Bcl-X L .
To determine the eect of Bcl-X L on cytotoxicity, three clones each of Bcl-X L vs neo transfected MDA-MB-453 cells were exposed to dierent doses of ADR and assayed 72 h later for cell viability using the MTT assay. The Bcl-X L clones were signi®cantly more resistant to ADR than neo clones (Figure 3b) , consistent with the hypothesis that Bcl-X L plays a major role in cytoprotection by HGF/SF.
The Bcl-X L clones were signi®cantly more resistant than neo clones to induction of apoptosis by ADR, as indicated by the relative lack of interoligonucleosomal DNA fragmentation by agarose gel electrophoresis ( Figure 4a ). Consistent with these results, signi®cantly fewer apoptotic cells were detected by terminal deoxytransferase (TdT) labeling of apoptotic DNA in ADR-treated Bcl-X L cultures than in similarly treated neo cell cultures (Figure 4b,c) . Finally, and somewhat suprisingly, the Bcl-X L cell clones showed an increased rate of repair of DNA strand breaks induced by ADR (Figure 5a ) and by 60 Co gamma radiation (Figure 5b ). These ®ndings suggest that not only is Bcl-X L involved in cytoprotection by blocking the induction of apoptosis, but Bcl-X L may also play a role in enhancing the repair of DNA damage.
HGF/SF does not further protect MDA-MB-453 Bcl-X L cell clones against DNA-damaging agents Next, we treated three clones each of neo and Bcl-X L transfected cells+HGF/SF (100 ng/ml648 h), exposed the cells to ADR, and analysed for cell viability 72 h later using the MTT assay. As shown in Figure 6a , neo clones were signi®cantly protected by HGF/SF against ADR: the ED 50 values (i.e., doses of ADR required for 50% loss of cell viability) were 9.5 mM in the absence of HGF/SF, as compared with 19 mM in the presence of SF. However, Bcl-X L cell clones showed similar ED 50 values (ca. 25 mM) in the absence or presence of HGF/ SF. Note that in the absence of HGF/SF, the Bcl-X L clones were somewhat more resistant that the neo clones in the presence of HGF/SF, suggesting that constitutive expression of Bcl-X L more fully protects MDA-MB-453 cells than exposure to HGF/SF. 
Protection of MDA-MB-453 cells by HGF/SF is phosphatidylinositol-3'-kinase (PI3K) dependent
To determine if HGF/SF cytoprotection involves a PI3K-dependent signaling pathway(s), we tested the eect of wortmannin (Wm), a selective PI3K enzymatic inhibitor, on protection against ADR cytotoxicity and on repair of ADR-induced DNA strand breaks. Cells were pre-incubated with HGF/SF and wortmannin for 48 h, followed by exposure to ADR and postincubation as usual. To correlate the results obtained from the MTT assays, the degree of protection against toxicity aorded by HGF/SF was calculated as shown below, where S represents the cell viability relative to untreated control cells:
Wm caused a reduction in the degree of HGF/SFmediated protection against 10 or 25 mM of ADR (Table 1a ). In the absence of ADR, 50 nM Wm caused no loss of cell viability, and only a very slight reduction of viability in cells treated with Wm+ADR as compared with ADR alone. In addition to partially but signi®cantly inhibiting protection against ADR by HGF/SF, Wm (50 nM) caused a reduction in the ability of HGF/SF to stimulate repair of ADR-induced SSBs ( Figure 7 ). Wm itself did not induce SSBs, nor did it cause an increase in the number of ADR-induced SSBs. However, cells treated with (Wm+HGF/ SF+ADR) had more residual SSBs than cells treated with (HGF/SF+ADR) at 24 h after exposure to ADR. In contrast to Wm, neither the MEK1 (MAP kinase kinase) inhibitor PE98059 nor the protein kinase C inhibitor GF109302X signi®cantly altered the ability of HGF/SF to protect against ADR (Table 1a) or to stimulate the repair of DNA breaks (Figure 7 ). Similar results were obtained when the DNA-damaging agent tested was ionizing radiation rather than ADR (Table  1b) . These ®ndings suggest that HGF/SF protection and enhancement of DNA repair are due, in part, to a pathway(s) involving PI3K.
If the main eect of the PI3K survival pathway is to enhance the expression of Bcl-X L under stressful conditions, then Wm should have little or no eect on the DNA damage response of Bcl-X L transfected cells. Thus, we tested the ability of Wm (50 nM) to modulate the viability of Bcl-X L transfected MDA-MB-453 cell clones treated with ADR. Treatment of control (neo) clones with Wm resulted in signi®cant inhibition of the SF-mediated protection against ADR. However, Wm caused only a slight drop in viability of ADR-treated Bcl-X L cell clones. Moreover, the survival of Bcl-X L clones in the presence of Wm was still higher than that of neo clones treated with (HGF/ SF+ADR) in the absence of Wm (data not shown). Thus, Wm failed to overcome the chemoresistance mediated by Bcl-X L expression. Subcon¯uent  proliferating  cells were incubated+ADR (20 mM62 h), washed, and incubated for 24 h in fresh drug-free culture medium. Cells were harvested, and equal aliquots of total cell protein (100 mg per lane) were analysed for Bcl-X L or a-actin by Western blotting. The panel on the bottom shows densitometry of the Bcl-X L band relative to a-actin as a control for loading and transfer. Values are means+s.e.m.s for three clones. Bcl-X L levels in the presence (+) or absence (7) or ADR were higher for Bcl-X L than for neo clones (P50.001). (b) Constitutive Bcl-X L expression protects MDA-MB-453 cells against ADR cytotoxicity. Two clones of each type (Bcl-X L vs neo) were exposed to ADR (2 h), washed, post-incubated for 72 h in drugfree medium, and assayed for cell viability by MTT dye conversion. Values are means+ranges of the average cell viability for two clones. For each clone, the average cell viability (relative to sham-treated control cells) was calculated from 10 replicate wells. Comparisons of cell viability for either neo clone vs either Bcl-X L showed highly signi®cant dierences (P50.001) Activation of a PI3K/c-Akt signaling pathway by HGF/SF c-Akt (aka. protein kinase-B), the cellular homolog of the viral transforming protein v-Akt, is a protein kinase down-stream of PI3K that has been implicated in growth factor signaling related to cell survival (Kennedy et al., 1997 (Kennedy et al., , 1999 Kolik et al., 1997) . We used an antibody reactive only against phosphorylated c-Akt (on serine 473) and another antibody reactive against total (phosphorylated and unphosphorylated) c-Akt to assess the ability of HGF/SF to activate of cAkt in MDA-MB-453 cells. These assays demonstrated an HGF/SF-induced increase in the fraction of phosphorylated to total c-Akt, that was blocked by the presence of Wm (50 nM) during incubation with HGF/SF (Figure 8 ). HGF/SF pre-treatment induced about a twofold increase in the fraction of phosphorylated to total c-Akt in cells treated without or with ADR. Of course, alterations in the phosphorylation of residues other than serine 473 would not be detected by this assay. We could not detect Bad on Western blots of MDA-MB-453 lysates; so it was not possible to determine if HGF/SF caused alterations in the expression or phosphorylation of Bad (data not shown). To further investigate the role of c-Akt in HGF/SFmediated cell protection and DNA repair, several dierent Akt expression vectors (Cong et al., 1997) were transiently transfected to determine their eects on cell viability (MTT assay) and DNA repair (®lter elution assay). Under conditions in which HGF/SF gave close to 100% protection against ADR in vectortransfected cells, the dominant negative (DN, kinase inactive) Akt reduced the degree of protection to about 50% for MDA-MB-453 cells (Figure 9a ) and 20% for Madin-Darby canine kidney epithelial cells (data not shown). In cells transfected with constitutively active Akt (Akt-myr), the survival of ADR-treated cells was 90% or more even in the absence of HGF/SF, indicating that constitutive activation of the Akt signaling pathway induces protection and obviates the requirement for HGF/SF for survival.
With regard to DNA repair, under control conditions, pre-incubation with HGF/SF reduced the number of residual DNA single strand breaks from about 40% to very low levels (0 ± 5%) at 24 h post exposure to ADR. When wild-type Akt (wtAkt) or constitutively active Akt were transfected, the number of breaks even in the absence of SF was decreased. But when the DN Akt was transfected, the number of residual breaks was still high in cells treated with HGF/SF+ADR (24%). These ®ndings suggest that inhibition of Akt using the DN Akt partially but signi®cantly inhibits HGF/SF-mediated cell survival and DNA repair.
Discussion
We showed that in addition to protecting human cancer cells against cytotoxicity and apoptosis caused by DNA-damaging agents (e.g., ADR, ionizing radiation), HGF/SF enhances the rate of repair of DNA strand breaks generated by these agents. We had previously documented that pre-treatment with HGF/ SF blocks down-regulation of the levels of the antiapoptotic protein Bcl-X L in ADR-treated MDA-MB-453 breast cancer cells. We have now shown that the HGF/SF-mediated protection of MDA-MB-453 cells against loss of cell viability and apoptosis is fully mimicked by unregulated expression of Bcl-X L . Expression of Bcl-X L in these cells also mimicked the HGF/SF-mediated enhancement of DNA repair. The later ®nding was surprising, since a role for Bcl-2 family anti-apoptosis proteins in DNA repair has not been described. Although activation of the c-Met receptor by HGF/SF is likely to activate a variety of cellular signaling pathways, one of which may aect Co gamma radiation and assayed for DNA repair activity as described in Figure 1 . Values are means+ranges for two clones of each type. For each clone, the per cent DNA eluted was determined using duplicate assays. Based on the pooled data for the two clones of each type, values of per cent DNA Eluted for the neo vs Bcl-X L diered signi®cantly (P50.001) Oncogene HGF/SF enhances DNA repair S Fan et al DNA repair, it is apparent that expression of Bcl-X L alone is sucient to activate a DNA repair pathway.
We considered the possibility that interoligonucleosomal DNA fragmentation occurring in cells undergoing apoptosis might be observed as DNA strand breaks in the DNA ®lter elution assays. In this case, a reduction in the number of strand breaks 24 h after exposure of Bcl-X L transfected MDA-MB-453 cells could simply re¯ect resistance to apoptosis conferred by over-expression of the Bcl-X L protein. However, several considerations rule against this possibility. First, the number of strand breaks immediately after The speci®cities of the inhibitors are as follows: wortmannin (P13K); PD98059 (MEK1); and GF109302X (PK-C). Note: The values of per cent protection were calculated based on the formulas shown in the text. Each assay condition was tested using 10 replicate wells. For both the ADR and the Radiation experiments, direct comparisons of cell viability for HGF/SF (+Inhibitor) vs HGF/SF (Control) yielded P50.001 for wortmannin, but were not signi®cant (P40.05) for PD98059 or for GF109302X
exposure to ADR (T=0) was similar in Bcl-X L was similar in Bcl-X L vs control cells, and declined over the next 24 h, indicative of a repair process. In principle, once cells that have entered into apoptosis undergo a signi®cant amount of DNA fragmentation, they pass a critical cell death checkpoint, beyond which cellular repair and survival is no longer possible (Chao and Korsmeyer, 1998). Thus, it seems unlikely that apoptotic DNA damage is repaired. However, it remains possible that the environment within a cell undergoing apoptosis is less conducive to repair of DNA strand breaks. For example, proteins implicated in the process of DNA repair [e.g., PARP (poly (ADP ribose) polmerase) and the ATM (ataxiatelangiectasia mutated) protein] are targets for degradation by caspases (Smith et al., 1999) . In this case, the ability of Bcl-X L to block apoptosis per se could contribute to an increased rate of DNA repair.
Bcl-X L is thought to function as a mitochondrial pore-forming protein, similar to Bcl-2 (Muchmore et al., 1996) . Its mechanism of action is not entirely certain, but has been delineated in part. The dominant pro-apoptotic protein Bad displaces Bax from Bcl-X L , due to a higher anity interaction (Yang et al., 1995) . In contrast to the Bcl-X L :Bax interaction, which does not eectuate apoptosis, a Bcl-X L :Bad interaction leads to apoptosis. The apoptogenic activity of Bad is regulated by its phosphorylation state. Hypo-phosphorylated Bad interacts with Bcl-X L , while phosphorylation on serine residues 112 and 136 allows it to interact with the signaling protein 14-3-3 rather than with Bcl-X L (Zha et al., 1996 (Zha et al., , 1997 . Since Bcl-X L , Bcl-2, Bad, and Bax are localized in the cytoplasm and/or outer mitochondrial membrane, it is not certain how alterations in the levels or interactions of these proteins might aect the DNA repair process. However, several recent studies indicate that 14-3-3 proteins can modulate nuclear signaling related to the DNA-damage response (Waterman et al., 1998; Chen et al., 1999) .
The cytoprotective activities of HGF/SF (reduction of cytotoxicity and enhancement of DNA repair) were partially inhibited by wortmannin, suggesting they are PI3K-dependent. The inability of Wm to fully inhibit HGF/SF-mediated protection in some experiments (see Table 1 ) may be due to a second, PI3K-independent survival pathway, or to an insucient dose of Wm to fully block PI3K. Higher doses of Wm were not tested because of its non-speci®c toxicity. HGF/SF treatment of MDA-MB-453 cell caused phosphorylation of cAkt, a protein kinase down-stream of PI3K that has been implicated in cell survival pathways (Kennedy et al., 1997 (Kennedy et al., , 1999 Datta et al., 1997) . Increased phosphorylation of c-Akt was observed in cells treated with HGF/SF alone or with (HGF/SF+ADR); and the HGF/SF-induced phosphorylation of c-Akt was blocked by wortmannin. On the other hand, selective inhibitors of the MAP kinase and protein kinase C pathways failed to inhibit cytoprotection or DNA repair, suggesting that these pathways are not directly involved in protection mediated by HGF/SF.
In the c-Akt phosphorylation experiments, the cells were pre-treated with HGF/SF for 48 h, washed to remove HGF/SF, exposed to ADR for 2 h, and then incubated for 24 h prior to harvesting for Western blotting. Thus, at least one day elapsed between removal of HGF/SF and assessment of c-Akt phosphorylation. The fact that phosphorylation of c-Akt protein was observed at the 24 h time point suggests that pre-incubation with HGF/SF may not only induce the phosphorylation of c-Akt but may also inhibit the de-phosphorylation of c-Akt. For example, HGF/SF could cause down-regulation of expression of the Figure 7 Enhancement of DNA repair by HGF/SF is phosphatidylinositol-3'-kinase (PI3K) dependent. Single-strand DNA breaks were assayed immediately (T=0) and at T=24 h after exposure to ADR, except that signaling inhibitors were present during the 48 h pre-incubation with SF. The numbers of SSBs present at T=0 were the same under all experimental conditions. The per cent of breaks repaired during the interval from 0 to 24 h post ADR treatment was calculated. For each experimental condition and inhibitor, two replicate determinations were made; and the ranges of values were within+5% of the mean values. Of the three inhibitors tested, only wortmannin blocked the ability of SF to mediate repair of SSBs Figure 8 HGF/SF induces the phosphorylation of c-Akt in MDA-MB-453 breast cancer cells. Cells were pre-incubated+HGF/SF (100 ng/ml) in the absence or presence of wortmannin (50 nM), washed, exposed to ADR (20 mM62 h), post-incubated in drug-free, HGF/SF-free medium for 24 h, and harvested for Western blotting speci®c phosphatase(s) that are responsible for inactivation of c-Akt.
Studies utilizing wild-type and several mutant Akt expression vectors suggest that a dominant negative Akt vector can partially block the ability of HGF/SF to protect cells against ADR-induced apoptosis and to enhance the rate of DNA repair. On the other hand, wild-type and constitutively active Akt vectors increased the cell viability and DNA repair activity in ADRtreated cells even in the absence of HGF/SF. Coupled with the phosphorylation experiments, these ®ndings suggest that the HGF/SF-mediated cytoprotection and stimulation of DNA repair are due, in part, to activation of the Akt signaling pathway. The ability of wild-type Akt to enhance cell viability and DNA repair in the absence of exogenous HGF/SF could be due to Akt activation by a low level of HGF/SF in the culture medium, which contained fetal calf serum. Alternatively, Akt may be partially activated by the presence of other growth factors from the fetal calf serum. This possibility is suggested by basal levels of phosphorylated Akt in the absence of exogenous HGF/SF.
The substrates of phosphorylated c-Akt involved in signaling related to HGF/SF-mediated cytoprotection and DNA repair remain to be identi®ed. One obvious candidate as an c-Akt survival pathway target is the proapoptic protein Bad, phosphorylation of which by cAkt inactivates its ability to function as a`death ligand' Figure 9 Eect of transient expression of dierent forms of Akt on HGF/SF-mediated protection. For MTT assays of cell viability (a), proliferating cells at about 60% of con¯uency were transfected overnight with each vector (10 mg per 100 mm dish) using lipofectamine, washed, and incubated another 24 h to allow expression of the dierent Akt proteins. The vectors tested were: control (empty vector), wild-type Akt (wtAkt), constitutively active Akt (Akt-myr), and dominant negative Akt (DNAkt). Cells were then harvested using trypsin and inoculated in 96-well dishes. Transfected cells were then incubated+HGF/SF (100 ng/ml for 48 h), exposed to ADR for 2 h, post-incubated in fresh drug-free medium for another 48 h, and assayed for MTT dye conversion. For DNA repair assays (b), cells were transfected and incubated as above in 60 mm dishes, then treated with HGF/SF, exposed to ADR, post-incubated in drug-free medium, and then harvested for DNA ®lter elution assays. Values of cell viability are means+s.e.m.s of 20 wells corresponding to transfections of two separate transfections. Values of per cent DNA eluted are means+s.e.m.s from four plates corresponding to two independent experiments. Comparisons of cell viability and DNA repair for ADR alone vs (HGF/SF+ADR) gave P50.001
for Bcl-X L (Zha et al., 1996; Datta et al., 1997) . Whether for technical reasons or low expression levels, we were unable to detect Bad in MDA-MB-453 studies, so we cannot assess its role in HGF/SF-mediated cell protection. Several other potential targets of the activated c-Akt kinase have been identi®ed that may be involved in signaling for anti-apoptosis and cell survival. For example, glycogen synthase kinase-3 (GSK-3), a physiologic target of c-Akt, is inhibited by phosphorylation, leading to inactivation of the ability of GSK-3 to induce apoptosis in several dierent cell types (Pap and Cooper, 1998) . GSK-3 is a signaling intermediate in the LEF-1/b-catenin pathway for transcriptional regulation . c-Akt can phosphorylate and inactivate FKHRL1, a member of the Forkhead family of transcription factors that functions to induce genes that can trigger apoptosis (Brunet et al., 1999) . Interestingly, the phosphorylation of c-Akt activates a 14-3-3 protein being site, resulting in binding of 14-3-3 proteins and inability of the FKHRL1:14-3-3 complex to translocate to the nucleus. The c-Akt kinase enhances the activity of human telomerase, an enzyme that may mediate cancer cell survival by restoring telomere length, by phosphorylating the reverse transcriptase subunit (Kang et al., 1999) . And ®nally, c-Akt can activation can inhibit apoptosis and cytochrome c release from mitochondria independently of any eects on the steady-state levels of Bcl-2 and Bcl-X L or on the phosphorylation state of Bad (Kennedy et al., 1999) . Thus, identifying which of these pathways are regulated by HGF/SF should lead to further insight into the role of HGF/SF in cell survival, DNA repair, and transformation.
The ®nding that HGF/SF can enhance DNA repair activity and down-regulate apoptosis pathways has potential implications for understanding carcinogenesis as well as chemosensitivity to clinically used DNAdamaging agents such as adriamycin and ionizing radiation. Because it can block apoptosis pathways, HGF/SF might actually enhance mutagenicity following DNA damage, by allowing cells with genetic damage to survive. Furthermore, the DNA ®lter elution assay of repair of single-and double-strand DNA breaks is a relatively crude assay. Some types of DNA repair ± even though they contribute to cell survival by preventing loss of essential genetic material ± may tend to promote carcinogenesis: e.g., nonhomologous recombination. And enhanced DNA repair occurring in tumors containing high levels of HGF/SF could render these tumors more resistant to DNA damaging chemotherapeutic agents by preventing the loss of genetic material and reducing the stimulus (unrepaired DNA strand breaks) for activation of apoptosis. While it remains to be determined whether the ability of HGF/SF to stimulate DNA repair is pro-or anti-carcinogenetic, the presence of HGF/SF in established tumors is probably deleterious because it leads to chemoresistance. 
Materials and methods

Sources of reagents and antibodies
Cell lines and culture
Human breast cancer (MDA-MB-453 and T47D) and prostate cancer (DU-145) cells were obtained from the American Type Culture Collection (Rockville, MD, USA). Cells were cultured in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 5% (DU-145) or 10% (MDA-MB-453, T47D) fetal calf serum (v/v), 5 mM glutamine, 100 mg/ml streptomycin, and 100 units/ml penicillin. Cell culture reagents were obtained from Bio Whittaker (Walkersville, MD, USA).
Expression vectors and cell transfections
The human full-length Bcl-X L cDNA (kindly provided by Dr EV Prochownik, Children's Hospital of Pittsburgh, Pittsburgh, PA, USA) was cloned into the EcoRI site of the pcDNA3.1 mammalian expression vector (Invitrogen, Carlsbad, CA, USA). Parental MDA-MB-453 breast cancer cells were transfected overnight with the Bcl-X L vector or the empty pcDNA3.1 vector (neo), using lipofectamine. Cells were selected in neomycin and clones were isolated and screened for Bcl-X L expression as described in the text.
The Akt expression vectors were provided by Dr Michael J Quon (National Heart, Lung, and Blood Istitute, National Institutes of Health, Bethesda, MD, USA) (Cong et al., 1997) . These included vectors encoding wild-type Akt, a constitutively active Akt (Akt-myr), a dominant negative kinase inactive (K179A) Akt, and the empty vector pCSI2). For transient transfections of Akt and control vectors, subcon¯uent proliferating cells were transfected overnight using lipofectamine and then washed thoroughly to remove the excess vector and lipofectamine.
Cell treatments
Adriamycin Subcon¯uent proliferating cells in 100 mm plastic dishes or 96-well plates were pre-incubated+HGF/ SF (100 ng/ml648 h) and then sham-treated (control) or treated with ADR (2 h at 378C) in complete culture medium (DMEM plus 5 or 10% fetal calf serum). Cultures were then washed twice, post-incubated in fresh drug-free complete culture medium at 378C for 24 or 72 h, and harvested for assays of DNA fragmentation, DNA repair activity, protein expression, or cell viability.
Irradiation Cells were treated+HGF/SF and then exposed to 60 Co gamma radiation (average energy 1.1 Mev photons) at a dose rate of 100 cGy per minute at 258C. Cells were washed, incubated in fresh complete culture medium for 24 or 72 h, and assayed as described below.
DNA fragmentation assays
DNA fragmentation was assessed by agarose gel electrophoresis (Herrman et al., 1994) . Cells were harvested by centrifugation, washed twice in phosphate-buered saline (PBS) and then resuspended in 200 ml of lysis buer (50 mM Tris-HCl, pH 7.5, 0.1 M EDTA, and 1% NP-40). The supernatants were incubated with 1% SDS and 5 mg/ml of RNase A for 2 h at 378C and treated overnight with 2.5 mg/ ml of proteinase K at 568C. DNA was precipitated with 1/2 volume of 10 M ammonium acetate and 2.5 volumes of 95% ethanol. Precipitated DNA was dissolved in gel loading buer and analysed by electrophoresis on a 1.5% agarose gel containing 0.1 mg/ml of ethidium bromide to visualize DNA ladders. The gels were photographed under ultraviolet light.
DNA filter elution assays
Subcon¯uent proliferating cells were labeled with 3 Hthymidine (0.02 mCi/ml632 h); chased for 2 h in isotope-free medium; exposed to ADR or radiation (see above); washed twice; incubated in fresh drug-free complete culture medium for 24 h; and counted by hemacytometer. Equal numbers of cells (2610 6 ) were loaded onto non-proteinizing polycarbonate ®lters, lysed, and subjected to alkaline elution or neutral elution (Bertrand and Pommier, 1995) . Radioactivity in the DNA fractions was counted; and the fraction of DNA eluted was calculated as elution fraction/[®lter+lysis+elution fraction]. Elution of DNA under alkaline conditions re¯ects the presence of single-strand breaks (SSBs); while elution under neutral conditions re¯ects double-strand breaks (DSBs).
MTT cell viability assay
This assay is based on the ability of viable mitochondria to convert MTT, a soluble tetrazolium salt [3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide] into an insoluble formazan precipitate, which is dissolved in dimethyl sulfoxide and quantitated by spectrophotometry (Alley et al., 1988) . Cells were seeded into 96-well dishes (2000 cells per well) in standard growth medium, incubated for 48 h to allow attachment and entry into the cell cycle, pre-incubated+HGF/SF (100 ng/ml648 h), treated with ADR or irradiated, post-incubated for 72 h, and tested for MTT conversion. Absorbance was read at 570 nm using a Dynatech 96-well spectrophotometer. Cell viability was calculated as the amount of MTT dye conversion relative to sham-treated control cells.
Western blotting
Cells were centrifuged, washed with PBS, and lysed at 08C for 30 min in lysis buer (1% NP-40, in PBS containing 2 mM 4-(2-aminoethylbenzensulfonyl¯uoride, 10 mg/ml leupeptin, 10 mg/ml aptotinin, 10 mM NaF, 1 mM Na orthovandate, and 5 mM Na pyrophosphate, 100 ± 200 ml per 100 mm dish). Protein content was determined using the Bio-Rad dye-binding microassay (Bio-Rad, Hercules, CA, USA); and 100 mg protein per lane was electrophoresed on 12% SDS polyacrylamide gels after boiling for 5 min in Laemmli sample buer. Proteins were blotted onto Imobilon membranes (Millipore, Bedford, MA, USA). Equal protein loading was con®rmed by fast green staining of the membrane and by blotting for a-actin as a control for loading and transfer. Colored markers (Bio-Rad) were used as size standards. After electroblotting, the membranes were blocked in PBS-Tween blocking buer containing 5% non-fat dry milk, washed with PBS-Tween buer, and incubated with the primary antibody diluted in blocking buer for 1 h. Primary antibody dilutions were those recommended by the manufacturers. Membranes were then washed, incubated with the appropriate second antibody (1 : 3000) in blocking buer for 1 h, and re-washed. Blotted proteins were detected using the enhanced chemiluminescence detection system (Amersham Life Sciences). Protein bands were quantitated by densitometry and expressed relative to a-actin.
Data analysis
Data are expressed as means+s.e.m.s, where three or more determinations were made, or means+ranges, where two determinations were made. Where applicable, statistical comparisons were carried out using the two-tailed Student's t-test. For some assays (DNA ®lter elution), two replicate determinations were made; and in these cases, the ranges of the data were within +5% of the mean values. In all cases, at least two independent experiments were performed to assure the reproducibility of the ®ndings.
